Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial
BACKGROUND: Ultrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on synthetic polymers of aspartic acid which is eliminated from the blood stream via phagocytosis. LK565 forms very st...
Na minha lista:
| Udgivet i: | Cardiovasc Ultrasound |
|---|---|
| Principais autores: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC520823/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15357870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-7120-2-16 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
